impact factor, citescore

Letters to the Editor


Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry

1, 2, 3, 4, 5, 6


  1. McMaster University, Hamilton, ON, Canada.
  2. Credit Valley Rheumatology, University of Toronto, ON, Canada.
  3. Nexus Clinical Research, St. John’s, NF, Canada.
  4. McMaster University, Hamilton, ON, Canada.
  5. Janssen Inc., Toronto, ON, Canada.
  6. Janssen Inc. Toronto, ON, Canada.

2020 Vol.38, N°2
PI 0371
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 31820720 [PubMed]

Received: 16/10/2018
Accepted : 04/08/2019
In Press: 18/11/2019
Published: 26/03/2020

Rheumatology Article